Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Prostate Cancer Test Valuable in Predicting Biopsy Need

By LabMedica International staff writers
Posted on 07 Nov 2011
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies.

The PSA test is particularly important in men as a predictor of the need for surgical intervention and prognosis of low-risk cancer or likely to be diagnosed with a low-risk of neoplasm. More...


A PSA test is a common way for physicians to determine a patient's potential risk of developing prostate cancer. The test measures the amount of PSA, a protein produced by cells of the prostate gland, in the patient's blood. Since 1990, the Mayo Clinic (Rochester, MN, USA) have prospectively studied more than 600 men between the ages of 40 and 79 for prostate outcomes.

Elevated PSA levels may result from a number of factors, including benign prostate enlargement or inflammation of the urinary tract, which is why additional tests are used in conjunction with the PSA test. For example, if the patient's physician suspects cancer, a biopsy of prostate cells likely will be ordered to confirm the diagnosis. The Mayo Clinic study found that men in their forties with a baseline PSA at or above the median PSA were much more likely to undergo a biopsy and to be diagnosed with low-risk prostate cancer; a similar trend was found for men in their fifties. However, the majority of tumors found in both age groups were classified as "low risk."

However, the PSA test is not without controversy. R. Jeffrey Karnes, MD, a Mayo Clinic urologist said "The decision to use the PSA test is best made by the patient, in consultation with his doctor. As we continue to refine our approach to diagnosing and treating prostate cancer, we believe the findings of this study will help clinicians and their patients make informed decisions.” The findings were presented at a meeting of the North Central Section of the American Urological Association held October 18 - 22 at Rancho Mirage (CA, USA).

Related Links:
Mayo Clinic
North Central Section of the American Urological Association



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.